Bigneat Ltd., a UK provider of high-performance safety solutions and laboratory products used in biopharmaceutical, biotechnology, academic research, and applied markets, has been sold to Caron Products and Services, a US provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy, and academic research. Caron is a portfolio company of SFW Capital Partners. Terms of the private transaction were not disclosed.
Founded in 1972 and based in Hampshire, England with operations in the U.S., Bigneat is a world-class manufacturer and leading global provider of clean air, hazard containment and safety systems to scientific laboratories and industry. Applications for Bigneat’s products cover operator and process/sample protection during laboratory procedures, batch and on-line production processes. Bigneat sells its products to a diverse range of customers in the biological, chemical, electronics, food, government, nanotechnology, pharmaceutical, photonics, universities, and schools, for QA/research laboratories and sterile production areas.
Founded in 1985 in Marietta, OH, Caron is a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy, and academic research. Caron’s products, which include environmental testing chambers, incubators and growth chambers, are used for FDA-required QA/QC stability testing during drug development and manufacturing, cell culture in clean-room environments, and growth of samples in academic research. Caron sells its products to a diverse range of customers in the biopharmaceutical, biotechnology, outsourced pharmaceutical services, industrial testing, consumer products, and public research markets, among others.
EC M&A acted as exclusive financial advisor to Bigneat on this transaction.
